Young Do Kwon

USPTO Granted Patents = 15 (Patent Applications = 7)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 56(Granted Patents)

Location History:

Cupertino, CA (US) (1979)
Rockville, MD (US) (2017 - 2020)
Bethesda, MD (US) (2016 - 2023)
Kensington, MD (US) (2016 - 2024)

Company Filing History:

11 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

7 out of 193

New York Blood Center, Inc.

National Institutes of Health

patents

5. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1979-2024

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12043660 - 10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use (2024-07-23),

2. 11760790 - Neutralizing antibodies to HIV-1 Env and their use (2023-09-19),

3. 11571409 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2023-02-07),

4. 11236152 - Neutralizing antibodies to HIV-1 GP41 and their use (2022-02-01),

5. 11059808 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2021-07-13),

6. 10869856 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2020-12-22),

7. 10815295 - Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein (2020-10-27),

8. 10576059 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2020-03-03),

9. 10413527 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2019-09-17),

10. 10137107 - Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV (2018-11-27),

11. 10035844 - Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein (2018-07-31),

12. 9695230 - Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein (2017-07-04),

13. 9403763 - CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof (2016-08-02),

14. 9309237 - HIV inhibitors (2016-04-12),

15. 4171503 - Electrodeless fluorescent lamp (1979-10-16),

Title: Young Do Kwon: Pioneering Innovations in HIV Treatment

Introduction:

Young Do Kwon, a talented inventor based in Bethesda, MD, has made significant contributions to the field of HIV treatment with his groundbreaking inventions. With a total of 13 patents to his name, Kwon's work focuses on developing novel solutions to combat HIV and related conditions.

Latest Patents:

Kwon's latest patents showcase his innovative approach to neutralizing antibodies targeting HIV-1 Env and their therapeutic use. These antibodies, along with their encoding nucleic acids, vectors, and host cells, have the potential to revolutionize HIV detection and treatment. Additionally, his work on substituted phenylpyrrolecarboxamides highlights promising therapeutic agents for HIV infection.

Career Highlights:

Having worked with prestigious institutions such as The United States of America (represented by the Department of Health and Human Services) and New York Blood Center, Inc., Kwon has honed his skills in the field of biomedical research. His patents reflect his commitment to pushing the boundaries of HIV treatment strategies and improving patient outcomes.

Collaborations:

Throughout his career, Kwon has collaborated with esteemed professionals in the field, including Asim Kumar Debnath and Francesca Curreli. These partnerships have enabled Kwon to leverage diverse expertise and drive innovation in his research endeavors.

Conclusion:

Young Do Kwon stands as a beacon of innovation in the realm of HIV treatment, with a prolific patent portfolio that underscores his dedication to advancing medical solutions. His collaborations and career highlights are a testament to his unwavering commitment to improving healthcare outcomes for individuals affected by HIV.

This text is generated by artificial intelligence and may not be accurate.